Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients

Clinical trial NCT06228092 · COMPLETED

Trial details

NCT number: NCT06228092
Sponsor: Matias Vested
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blockade, Residual

Start date: 2023-12-04
Primary completion: 2025-05-04
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.